Tus kws kho mob
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2771 - 2780 ntawm 4179
Tus kws kho mob
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P54-16 Added Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2016
Tus kws kho mob
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2017
Tus kws kho mob
P59-18 New Acupuncture Update for Commercial Lines of Business - Effective January 1, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2017
Tus kws kho mob
P53-17 New Drug-Related Prior Authorization Requirements for Edaravone (Radicava) and Cerliponase Alfa (Brineura)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 10, 2017
Tus kws kho mob
P58-16 Changes to Prior Authorization for Infertility for Commercial Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2016
Tus kws kho mob
P6-18 Addition of Drug to the Self-Administered Oncology PA with QL Program
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P48-16 Criteria Changes to Certain Services on the Prior Authorization List for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2016